Chiesi M, Rogg H, Eichenberger K, Gazzotti P, Carafoli E
Biochem Pharmacol. 1987 Sep 1;36(17):2735-40. doi: 10.1016/0006-2952(87)90257-7.
The benzothiazepine diltiazem is a potent Ca-channel blocker, which also inhibits the Na-dependent Ca-efflux from heart mitochondria. In this study, the action of the 4 stereoisomers of diltiazem has been investigated using guinea-pig heart and liver mitochondria. The rate of the Na-dependent Ca-efflux from liver mitochondria has been found to be 10 times smaller than in heart mitochondria. Otherwise, the exchange systems from the two tissues have been found to be pharmacologically indistinguishable. Both the (+)-optical isomers of the cis- and trans-forms of diltiazem inhibit Na-Ca exchange activity with comparable potency (IC50 of 10-20 microM), while the (-)-optical isomers are ineffective (IC50 greater than 200 microM). Radioligand binding experiments have revealed that only one stereoisomer of diltiazem, the (+)-cis form, interacts with high affinity with the Ca-channel receptors of guinea-pig heart sarcolemma preparations (KD = 120 nM). The results have shown that the Ca-channel of plasma membranes and the mitochondrial Na-Ca exchanger have different stereospecific requirements for the binding of diltiazem.
苯并硫氮䓬类药物地尔硫䓬是一种强效钙通道阻滞剂,它还能抑制心脏线粒体中依赖钠的钙外流。在本研究中,利用豚鼠心脏和肝脏线粒体研究了地尔硫䓬4种立体异构体的作用。已发现肝脏线粒体中依赖钠的钙外流速率比心脏线粒体中的小10倍。此外,已发现这两种组织的交换系统在药理学上无法区分。地尔硫䓬顺式和反式的(+)-光学异构体均以相当的效力抑制钠-钙交换活性(IC50为10 - 20微摩尔),而(-)-光学异构体则无效(IC50大于200微摩尔)。放射性配体结合实验表明,地尔硫䓬只有一种立体异构体,即(+)-顺式异构体,能与豚鼠心脏肌膜制剂的钙通道受体高亲和力结合(KD = 120纳摩尔)。结果表明,质膜钙通道和线粒体钠-钙交换体对与地尔硫䓬结合具有不同的立体特异性要求。